CNBXCNBX Pharmaceuticals Inc.

About CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Inc. (CNBX) is a Biotechnology company headquartered in Bethesda, MD, United States whose shares trade over-the-counter on the Pink tier.

CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.

Products and services

CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.

CNBX key facts

Ticker symbol

CNBX

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Bethesda, MD, United States

Country of incorporation

US

Employees

2

Estimated market cap

$237.0K (as of Apr 11, 2025)

Shares outstanding

33,861,352

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

8/31

CNBX Pharmaceuticals Inc. leadership

• Eyal Barad — CEO
• Gabriel Yariv — COO, President

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C